Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/27811
Title: High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Authors: 
Keywords: 
Mesh: 
Issue Date: Feb-2016
Citation: Oncologist.2016 Feb;(21)2:150-5
Abstract: In the neoadjuvant setting, changes in the proliferation marker Ki67 are associated with primary endocrine treatment efficacy, but its value as a predictor of response to chemotherapy is still controversial.
PMID: 26786263
URI: https://hdl.handle.net/20.500.12530/27811
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos

Files in This Item:
File Description SizeFormat 
PMC4746087.pdf624.19 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.